SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000930413-18-003124
Filing Date
2018-10-22
Accepted
2018-10-22 06:05:54
Documents
2
Period of Report
2018-10-19

Document Format Files

Seq Description Document Type Size
1 c92204_6k.htm 6-K 17609
2 c92204_ex10-1.htm EX-10.1 252586
  Complete submission text file 0000930413-18-003124.txt   271245
Mailing Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5
Business Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5 (514) 940-3600
Clementia Pharmaceuticals Inc. (Filer) CIK: 0001647320 (see all company filings)

IRS No.: 981128564 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38177 | Film No.: 181131467
SIC: 2834 Pharmaceutical Preparations